Literature DB >> 14999152

Rho GTPases as key transducers of proliferative signals in g1 cell cycle regulation.

Catherine F Welsh1.   

Abstract

Mitogenic growth factor- and integrin-dependent signaling pathways cooperate to control the proliferation of nontransformed cells. As integral mediators of these networks, the Rho family of GTPases play a pivotal role in G1 cell cycle progression, primarily through regulation of cyclin D1 expression, as well as the levels of the cyclin-dependent kinase inhibitors p21cip1 and p27kip1. Such dual control of both the critical positive and negative regulators of G1 progression make the Rho GTPases prime candidates to target the autonomous proliferation which typifies cancer cells. Cyclin D1 has been identified as an important oncogene and the cdk inhibitors as tumor suppressors in human breast carcinogenesis. Evidence pointing to the potential role of Rho-dependent pathways and their interaction with oncogenic Ras in contributing to such cell cycle abnormalities that characterize human breast cancer is also presented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999152     DOI: 10.1023/B:BREA.0000018425.31633.07

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  15 in total

1.  The Rho GTPase Cdc42 is required for primary mammary epithelial cell morphogenesis in vitro.

Authors:  Kristi Bray; Cord Brakebusch; Tracy Vargo-Gogola
Journal:  Small GTPases       Date:  2011-09-01

2.  Escherichia coli cytotoxic necrotizing factor 1 blocks cell cycle G2/M transition in uroepithelial cells.

Authors:  Loredana Falzano; Perla Filippini; Sara Travaglione; Alessandro Giamboi Miraglia; Alessia Fabbri; Carla Fiorentini
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  NMDA receptor activation induces translocation and activation of Rac in mouse hippocampal area CA1.

Authors:  Maria V Tejada-Simon; Laura E Villasana; Faridis Serrano; Eric Klann
Journal:  Biochem Biophys Res Commun       Date:  2006-03-10       Impact factor: 3.575

Review 4.  Rho GTPases: functions and association with cancer.

Authors:  Saskia I J Ellenbroek; John G Collard
Journal:  Clin Exp Metastasis       Date:  2007-11-14       Impact factor: 5.150

5.  Redundant functions of Rac GTPases in inner ear morphogenesis.

Authors:  Cynthia M Grimsley-Myers; Conor W Sipe; Doris K Wu; Xiaowei Lu
Journal:  Dev Biol       Date:  2011-12-11       Impact factor: 3.582

6.  Regulation of Cdc42 expression and signaling is critical for promoting corneal epithelial wound healing.

Authors:  Swetha Pothula; Haydee E P Bazan; Gudiseva Chandrasekher
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-09       Impact factor: 4.799

7.  Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.

Authors:  David R Croucher; Danny Rickwood; Carole M Tactacan; Elizabeth A Musgrove; Roger J Daly
Journal:  Mol Cell Biol       Date:  2010-08-30       Impact factor: 4.272

8.  Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells.

Authors:  Xiangshan Zhao; Lin Lu; Nidhi Pokhriyal; Hui Ma; Lei Duan; Simon Lin; Nadereh Jafari; Hamid Band; Vimla Band
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.

Authors:  Xiufeng Pang; Tingfang Yi; Zhengfang Yi; Sung Gook Cho; Weijing Qu; Decha Pinkaew; Ken Fujise; Mingyao Liu
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

10.  TGFBI deficiency predisposes mice to spontaneous tumor development.

Authors:  Ye Zhang; Gengyun Wen; Genze Shao; Cuidong Wang; Chyuansheng Lin; Hongbo Fang; Adayabalam S Balajee; Govind Bhagat; Tom K Hei; Yongliang Zhao
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.